Cargando…

Leveraging the microbiome to understand clinical heterogeneity in depression: findings from the T-RAD study

Alterations in the gut microbiome have been linked to a variety of mental illnesses including anxiety and depression. This study utilized advanced bioinformatics tools that integrated both the compositional and community nature of gut microbiota to investigate how gut microbiota influence clinical s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chin Fatt, Cherise R., Asbury, Sarah, Jha, Manish K., Minhajuddin, Abu, Sethuram, Sangita, Mayes, Taryn, Kennedy, Sidney H., Foster, Jane A., Trivedi, Madhukar H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147668/ https://www.ncbi.nlm.nih.gov/pubmed/37117195 http://dx.doi.org/10.1038/s41398-023-02416-3

Ejemplares similares

Immune characterization of suicidal behavior in female adolescents
por: Chin Fatt, Cherise R., et al.
Publicado: (2022)

Psychometric Properties of the Concise Associated Symptom Tracking Scale and Validation of Clinical Utility in the EMBARC Study
por: Minhajuddin, Abu, et al.
Publicado: (2020)

Higher S100B Levels Predict Persistently Elevated Anhedonia with Escitalopram Monotherapy Versus Antidepressant Combinations: Findings from CO-MED Trial
por: Jha, Manish K., et al.
Publicado: (2019)

Impact of the COVID-19 pandemic on adults with current and prior depression: initial findings from the longitudinal Texas RAD study
por: Czysz, Andrew H., et al.
Publicado: (2021)

Fibroblast growth factor 21 (FGF21) is increased in MDD and interacts with body mass index (BMI) to affect depression trajectory
por: Mason, Brittany L., et al.
Publicado: (2022)

Platelet-Derived Growth Factor as an Antidepressant Treatment Selection Biomarker: Higher Levels Selectively Predict Better Outcomes with Bupropion-SSRI Combination
por: Jha, Manish K, et al.
Publicado: (2017)

Worsening Anxiety, Irritability, Insomnia, or Panic Predicts Poorer Antidepressant Treatment Outcomes: Clinical Utility and Validation of the Concise Associated Symptom Tracking (CAST) Scale
por: Jha, Manish K, et al.
Publicado: (2017)

Prediction of Acute-Phase Treatment Outcomes by Adding a Single-Item Measure of Activity Impairment to Symptom Measurement: Development and Validation of an Interactive Calculator from the STAR*D and CO-MED Trials
por: Jha, Manish K, et al.
Publicado: (2019)

Early Improvement in Psychosocial Function Predicts Longer-Term Symptomatic Remission in Depressed Patients
por: Jha, Manish K., et al.
Publicado: (2016)

Daily activity level improvement with antidepressant medications predicts long-term clinical outcomes in outpatients with major depressive disorder
por: Jha, Manish K, et al.
Publicado: (2017)

Addressing adherence to antidepressant treatment for depression
por: Mayes, Taryn L., et al.
Publicado: (2020)

Brain Ventricle and Choroid Plexus Morphology as Predictor of Treatment Response: Findings from the EMBARC Study
por: Murck, Harald, et al.
Publicado: (2023)

Personalized Antidepressant Selection and Pathway to Novel Treatments: Clinical Utility of Targeting Inflammation
por: Jha, Manish K., et al.
Publicado: (2018)

The 9-item Concise Health Risk Tracking – Self-Report (CHRT-SR(9)) measure of suicidal risk: Performance in adult primary care patients
por: Nandy, Karabi, et al.
Publicado: (2023)

Brain Regulation of Emotional Conflict Predicts Antidepressant Treatment Response for Depression
por: Fonzo, Gregory A., et al.
Publicado: (2019)

Reward Behavior Disengagement, a Neuroeconomic Model-Based Objective Measure of Reward Pathology in Depression: Findings from the EMBARC Trial
por: Giles, Michael A., et al.
Publicado: (2023)

Considering depression as a secondary outcome in the optimization of physical activity interventions for breast cancer survivors in the PACES trial: a factorial randomized controlled trial
por: Rethorst, Chad D., et al.
Publicado: (2023)

The Concise Health Risk Tracking ‐ Self‐Report (CHRT‐SR)—A measure of suicidal risk: Performance in adolescent outpatients
por: Nandy, Karabi, et al.
Publicado: (2022)

Leveraging the Microbiome for Obesity: Moving From Form to Function
por: Lee, Anna H., et al.
Publicado: (2022)

The effectiveness of enhanced evidence-based care for depressive disorders: a meta-analysis of randomized controlled trials
por: Xiao, Le, et al.
Publicado: (2021)

Leveraging microbiome rediversification for the ecological rescue of soil function
por: King, William L., et al.
Publicado: (2023)

Accurately identifying patients who are excellent candidates or unsuitable for a medication: a novel approach
por: South, Charles, et al.
Publicado: (2017)

Leveraging heterogeneous network embedding for metabolic pathway prediction
por: M A Basher, Abdur Rahman, et al.
Publicado: (2020)

Probing and Leveraging the Structural Heterogeneity of Nanomaterials for Enhanced Catalysis
por: Yang, Rui, et al.
Publicado: (2023)

Cerebral Blood Perfusion Predicts Response to Sertraline versus Placebo for Major Depressive Disorder in the EMBARC Trial
por: Cooper, Crystal M., et al.
Publicado: (2019)

Informal nutrition symposium: leveraging the microbiome (and the metabolome) for poultry production
por: Lee, Margie D., et al.
Publicado: (2021)

Leveraging phylogenetic signal to unravel microbiome function and assembly rules
por: Talavera-Marcos, Silvia, et al.
Publicado: (2023)

Psychometrics of the Concise Health Risk Tracking Self-Report (CHRT-SR(16)) Assessment of Suicidality in a Sample of Adults with Moderate to Severe Methamphetamine Use Disorder: Findings from the ADAPT-2 Randomized Trial
por: Trombello, Joseph M, et al.
Publicado: (2023)

MARS: leveraging allelic heterogeneity to increase power of association testing
por: Hormozdiari, Farhad, et al.
Publicado: (2021)

The RAD51 and DMC1 homoeologous genes of bread wheat: cloning, molecular characterization and expression analysis
por: Devisetty, Upendra Kumar, et al.
Publicado: (2010)

Th17 cells sense microbiome to promote depressive-like behaviors
por: Medina-Rodriguez, Eva M., et al.
Publicado: (2023)

Leveraging explainable AI for gut microbiome-based colorectal cancer classification
por: Rynazal, Ryza, et al.
Publicado: (2023)

Leveraging pre-trained language models for mining microbiome-disease relationships
por: Karkera, Nikitha, et al.
Publicado: (2023)

Leveraging Single-Cell RNA Sequencing Experiments to Model Intratumor Heterogeneity
por: Ferrall-Fairbanks, Meghan C., et al.
Publicado: (2018)

Improve the model of disease subtype heterogeneity by leveraging external summary data
por: Fu, Sheng, et al.
Publicado: (2023)

BioREx: Improving Biomedical Relation Extraction by Leveraging Heterogeneous Datasets
por: Lai, Po-Ting, et al.
Publicado: (2023)

FedRAD: Heterogeneous Federated Learning via Relational Adaptive Distillation
por: Tang, Jianwu, et al.
Publicado: (2023)

Leveraging the positives from the pandemic to strengthen infectious disease care in low-income and middle-income countries
por: Titanji, Boghuma K, et al.
Publicado: (2023)

Leveraging Human Microbiome Features to Diagnose and Stratify Children with Irritable Bowel Syndrome
por: Hollister, Emily B., et al.
Publicado: (2019)

Leveraging Scheme for Cross-Study Microbiome Machine Learning Prediction and Feature Evaluations
por: Song, Kuncheng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rcmc9486e44fvq8j3lb4lu5k88